Evidence map›Paper›PMID 34670153›Full record

ArticleAgeing research reviews2021

Reply to "Caution in underrepresentation of older adults in clinical trials on COVID-19 vaccines".

Nicola Veronese, Mirko Petrovic, Athanase Benetos, Michael Denkinger, Adalsteinn Gudmundsson, Wilma Knol, Christine Marking, George Soulis, Stefania Maggi, Antonio Cherubini and 1 more

Abstract readLetterComment
PubMed Full text at PMC Publisher
In one paragraph

Article in Ageing research reviews, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

11 authors.

Nicola VeroneseDepartment of Internal Medicine and Geriatrics, University of Palermo, Palermo, Italy. Electronic address: nicola.veronese@unipa.it.
Mirko PetrovicSection of Geriatrics, Department of Internal Medicine and Paediatrics, Ghent University, Ghent, Belgium.
Athanase BenetosDepartment of Geriatrics and FHU CARTAGE-PROFILES, CHRU de Nancy and INSERM 1116, Université de Lorraine, Vandoeuvre-lès-Nancy, France.
Michael DenkingerInstitute for Geriatric Research at Agaplesion Bethesda Hospital Ulm, Ulm University and Geriatric Centre Ulm, Germany.
Adalsteinn GudmundssonLandspitali University Hospital Reykjavik, Landspitali, Iceland.
Wilma KnolDepartment of Geriatric Medicine, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Christine MarkingMemory Disorder Research Group, Department of Neurology, Neuroscience Centre, Copenhagen University Hospital Rigshospitalet, Denmark.
George SoulisOutpatient Geriatric Assessment Unit, Henry Dunant Hospital Center, Athens, Greece.
Stefania MaggiCNR-IN Aging Branch-Padua, Italy.
Antonio CherubiniGeriatria, Accettazione geriatrica e Centro di ricerca per l'invecchiamento. IRCCS INRCA, Ancona, Italy.
special interest group in Systematic Reviews and Meta-analyses and the task force on Pharmaceutical strategy of the European Geriatric Medicine Society (EuGMS)

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19COVID-19 VaccinesAgedHumansSARS-CoV-2COVID-19 Vaccines

Identifiers

PMID34670153
PMCPMC8520503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.